Gri Bio Etf Cash Flow From Operations
| GRI Etf | USD 0.69 0.05 7.81% |
GRI Bio fundamentals help investors to digest information that contributes to GRI Bio's financial success or failures. It also enables traders to predict the movement of GRI Etf. The fundamental analysis module provides a way to measure GRI Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GRI Bio etf.
GRI |
GRI Bio ETF Cash Flow From Operations Analysis
GRI Bio's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current GRI Bio Cash Flow From Operations | (9.14 M) |
Most of GRI Bio's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GRI Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, GRI Bio has (9.14 Million) in Cash Flow From Operations. This is much lower than that of the Biotechnology family and significantly lower than that of the Health Care category. The cash flow from operations for all United States etfs is notably higher than that of the company.
GRI Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GRI Bio's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of GRI Bio could also be used in its relative valuation, which is a method of valuing GRI Bio by comparing valuation metrics of similar companies.GRI Bio is currently under evaluation in cash flow from operations as compared to similar ETFs.
Fund Asset Allocation for GRI Bio
The fund invests 99.63% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides GRI Bio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
GRI Fundamentals
| Return On Equity | -1.89 | ||||
| Return On Asset | -0.83 | ||||
| Current Valuation | 1.54 M | ||||
| Shares Outstanding | 8.93 M | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 4.70 % | ||||
| Number Of Shares Shorted | 924.63 K | ||||
| Price To Earning | 23.35 X | ||||
| Price To Book | 1.68 X | ||||
| Revenue | 21.77 M | ||||
| EBITDA | (10.9 M) | ||||
| Net Income | (13.04 M) | ||||
| Cash And Equivalents | 183.82 M | ||||
| Cash Per Share | 0.30 X | ||||
| Total Debt | 14 K | ||||
| Debt To Equity | 1.23 % | ||||
| Current Ratio | 5.23 X | ||||
| Book Value Per Share | 5.21 X | ||||
| Cash Flow From Operations | (9.14 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | 77.53 X | ||||
| Target Price | 12.0 | ||||
| Market Capitalization | 6.16 M | ||||
| Total Asset | 2.96 M | ||||
| Retained Earnings | (31.53 M) | ||||
| Working Capital | 237 K | ||||
| Current Asset | 1.22 B | ||||
| Current Liabilities | 243.82 M | ||||
| One Year Return | 12.82 % | ||||
| Three Year Return | 8.99 % | ||||
| Five Year Return | 5.20 % | ||||
| Ten Year Return | 8.79 % | ||||
| Net Asset | 2.96 M | ||||
| Last Dividend Paid | 0.51 | ||||
| Equity Positions Weight | 99.63 % |
About GRI Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GRI Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GRI Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GRI Bio based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in GRI Etf
GRI Bio financial ratios help investors to determine whether GRI Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GRI with respect to the benefits of owning GRI Bio security.